
Paresh Prataprai Mehta
About Paresh Prataprai Mehta
Data last updated:
Paresh Prataprai Mehta is a Director at Kilitch Healthcare India Limited (since 1998), Designated Partner at Kilitch Healthcare Llp (since 2012) and Partner at Growlease Fintech I Llp (since 2022), and holds 1 more current directorship. The companies operate in Pharma and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹67.50 Cr; the largest is Kilitch Healthcare India Limited at ₹63.63 Cr (FY 2024). Earlier, Paresh Prataprai Mehta was a Whole-Time Director at Kilitch Drugs (India) Limited (1992–2016) and Director at Kilitch Company (Pharma) Limited (1984–2016) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Dec 1998 | 1998 | ₹63.63 Cr (FY 2024) | Active | |
| Designated Partner | 17 Oct 2012 | 2012 | ₹3.87 Cr (FY 2023) | Active | |
| Partner | 29 Jul 2022 | 2021 | Active | ||
| Managing Director | 31 Dec 2009 | 2009 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 12 May 1992 | 1992 | ₹209 Cr (FY 2025) | Active | |
| Director | 10 Jan 1984 | 1983 | ₹1.9 Lakh (FY 2023) | Active | |
| Additional Director | 17 Jan 2014 | 2007 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Paresh Prataprai Mehta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Divya Paresh Mehta | 06391672 | Kilitch Healthcare India Limited , Kilitch Healthcare Llp and 1 more | Director |
| Mukesh Manmohandas Agashiwala | 06875336 | Kilitch Healthcare India Limited , Eye Kare Kilitch Limited | Director |
| Neha Paresh Mehta | 00148105 | Kilitch Healthcare India Limited , Kilitch Healthcare Llp and 1 more | Director |
| Bhupinder Narendra Garg | 03337727 | Growlease Fintech I Llp | Designated Partner |
| Shekhar Shrawankumar Bhuwania | 03604299 | Growlease Fintech I Llp | Designated Partner |
| Mukesh Damji Shah | 00893087 | Eye Kare Kilitch Limited | Director |
| Pradyumna Upendra Pande | 06876992 | Eye Kare Kilitch Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Paresh Prataprai Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paresh Prataprai Mehta
Paresh Prataprai Mehta currently holds 4 directorships: Kilitch Healthcare India Limited (Director, since 15 Dec 1998, revenue ₹63.63 Cr (FY 2024)); Kilitch Healthcare Llp (Designated Partner, since 17 Oct 2012, revenue ₹3.87 Cr (FY 2023)); Growlease Fintech I Llp (Partner, since 29 Jul 2022); Eye Kare Kilitch Limited (Managing Director, since 31 Dec 2009).
Paresh Prataprai Mehta was first appointed on 10 Jan 1984 as Director at Kilitch Company (Pharma) Limited. The most recent appointment on record is 29 Jul 2022 at Growlease Fintech I Llp.
The 2 current companies of Paresh Prataprai Mehta that report revenue have a combined latest revenue of ₹67.50 Cr: Kilitch Healthcare India Limited ₹63.63 Cr (FY 2024); Kilitch Healthcare Llp ₹3.87 Cr (FY 2023).
Paresh Prataprai Mehta held 3 earlier board appointments: Kilitch Drugs (India) Limited (Whole-Time Director, 12 May 1992 to 13 Apr 2016); Kilitch Company (Pharma) Limited (Director, 10 Jan 1984 to 06 Apr 2016); Vulcan Developers Private Limited (Additional Director, from 17 Jan 2014).
The current boards of Paresh Prataprai Mehta's companies include Divya Paresh Mehta (Kilitch Healthcare India Limited), Mukesh Manmohandas Agashiwala (Kilitch Healthcare India Limited), Neha Paresh Mehta (Kilitch Healthcare India Limited), Bhupinder Narendra Garg (Growlease Fintech I Llp), Shekhar Shrawankumar Bhuwania (Growlease Fintech I Llp), Mukesh Damji Shah (Eye Kare Kilitch Limited), among others.